Search Results - "Tijssen, Jan Gp"

Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity by Winter, Michiel M, Bernink, Flip Jp, Groenink, Maarten, Bouma, Berto J, van Dijk, Arie Pj, Helbing, Willem A, Tijssen, Jan Gp, Mulder, Barbara Jm

“…The method used to delineate the boundary of the right ventricle (RV), relative to the trabeculations and papillary muscles in cardiovascular magnetic…”
Get full text

Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study by Hirsch, Alexander, MD, Windhausen, Fons, MD, Tijssen, Jan GP, Prof, Verheugt, Freek WA, Prof, Cornel, Jan Hein, MD, de Winter, Robbert J, Dr

“…Summary Background The ICTUS trial was a study that compared an early invasive with a selective invasive treatment strategy in patients with non-ST-elevation…”
Get full text

Initiation of health-behaviour change among employees participating in a web-based health risk assessment with tailored feedback by Colkesen, Ersen B, Niessen, Maurice Aj, Peek, Niels, Vosbergen, Sandra, Kraaijenhagen, Roderik A, van Kalken, Coenraad K, Tijssen, Jan Gp, Peters, Ron Jg

“…Primary prevention programs at the worksite can improve employee health and reduce the burden of cardiovascular disease. Programs that include a web-based…”
Get full text

A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study by Teeuwen, Koen, Adriaenssens, Tom, Van den Branden, Ben J L, Henriques, José P S, Van der Schaaf, Rene J, Koolen, Jacques J, Vermeersch, Paul H M J, Bosschaert, Mike A R, Tijssen, Jan G P, Suttorp, Maarten J

“…Percutaneous recanalization of total coronary occlusion (TCO) was historically hampered by high rates of restenosis and reocclusions. The PRISON II trial…”
Get full text

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019 by Spitzer, Ernest, Ren, Ben, Brugts, Jasper J, Daemen, Joost, McFadden, Eugene, Tijssen, Jan Gp, Van Mieghem, Nicolas M

“…The coronavirus disease 2019 (COVID-19) pandemic started in Wuhan, Hubei Province, China, in December 2019, and by 24 April 2020, it had affected >2.73 million…”
Get full text

Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation by Sohns, Christian, Fox, Henrik, Marrouche, Nassir F., Crijns, Harry J.G.M., Costard-Jaeckle, Angelika, Bergau, Leonard, Hindricks, Gerhard, Dagres, Nikolaos, Sossalla, Samuel, Schramm, Rene, Fink, Thomas, El Hamriti, Mustapha, Moersdorf, Maximilian, Sciacca, Vanessa, Konietschke, Frank, Rudolph, Volker, Gummert, Jan, Tijssen, Jan G.P., Sommer, Philipp

“…In a randomized trial involving patients with advanced heart failure and atrial fibrillation, catheter ablation decreased the risk of cardiovascular events at…”
Get full text

Colchicine in Patients with Chronic Coronary Disease by Nidorf, Stefan M, Fiolet, Aernoud T.L, Mosterd, Arend, Eikelboom, John W, Schut, Astrid, Opstal, Tjerk S.J, The, Salem H.K, Xu, Xiao-Fang, Ireland, Mark A, Lenderink, Timo, Latchem, Donald, Hoogslag, Pieter, Jerzewski, Anastazia, Nierop, Peter, Whelan, Alan, Hendriks, Randall, Swart, Henk, Schaap, Jeroen, Kuijper, Aaf F.M, van Hessen, Maarten W.J, Saklani, Pradyot, Tan, Isabel, Thompson, Angus G, Morton, Allison, Judkins, Chris, Bax, Willem A, Dirksen, Maurits, Alings, Marco, Hankey, Graeme J, Budgeon, Charley A, Tijssen, Jan G.P, Cornel, Jan H, Thompson, Peter L

“…Patients with chronic coronary disease were randomly assigned to receive 0.5 mg of colchicine once daily or matching placebo. The incidence of the composite…”
Get full text

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement by Dangas, George D, Tijssen, Jan G.P, Wöhrle, Jochen, Søndergaard, Lars, Gilard, Martine, Möllmann, Helge, Makkar, Raj R, Herrmann, Howard C, Giustino, Gennaro, Baldus, Stephan, De Backer, Ole, Guimarães, Ana H.C, Gullestad, Lars, Kini, Annapoorna, von Lewinski, Dirk, Mack, Michael, Moreno, Raúl, Schäfer, Ulrich, Seeger, Julia, Tchétché, Didier, Thomitzek, Karen, Valgimigli, Marco, Vranckx, Pascal, Welsh, Robert C, Wildgoose, Peter, Volkl, Albert A, Zazula, Ana, van Amsterdam, Ronald G.M, Mehran, Roxana, Windecker, Stephan

“…Patients who had undergone successful TAVR were randomly assigned to receive either a rivaroxaban-based antithrombotic regimen or an antiplatelet-based…”
Get full text

Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study by Colkesen, Ersen B, Ferket, Bart S, Tijssen, Jan G P, Kraaijenhagen, Roderik A, van Kalken, Coenraad K, Peters, Ron J G

“…A large proportion of the cardiovascular disease (CVD) burden can potentially be prevented by primary prevention programs addressing major causal risk factors…”
Get full text

Subcutaneous or Transvenous Defibrillator Therapy by Knops, Reinoud E, Olde Nordkamp, Louise R.A, Delnoy, Peter-Paul H.M, Boersma, Lucas V.A, Kuschyk, Jürgen, El-Chami, Mikhael F, Bonnemeier, Hendrik, Behr, Elijah R, Brouwer, Tom F, Kääb, Stefan, Mittal, Suneet, Quast, Anne-Floor B.E, Smeding, Lonneke, van der Stuijt, Willeke, de Weger, Anouk, de Wilde, Koen C, Bijsterveld, Nick R, Richter, Sergio, Brouwer, Marc A, de Groot, Joris R, Kooiman, Kirsten M, Lambiase, Pier D, Neuzil, Petr, Vernooy, Kevin, Alings, Marco, Betts, Tim R, Bracke, Frank A.L.E, Burke, Martin C, de Jong, Jonas S.S.G, Wright, David J, Tijssen, Jan G.P, Wilde, Arthur A.M

“…Patients with an indication for an implantable cardioverter–defibrillator but no indication for pacing were randomly assigned to a subcutaneous or a…”
Get full text

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI by Wykrzykowska, Joanna J, Kraak, Robin P, Hofma, Sjoerd H, van der Schaaf, Rene J, Arkenbout, E. Karin, IJsselmuiden, Alexander J, Elias, Joëlle, van Dongen, Ivo M, Tijssen, Ruben Y.G, Koch, Karel T, Baan, Jan, Vis, M. Marije, de Winter, Robbert J, Piek, Jan J, Tijssen, Jan G.P, Henriques, Jose P.S

“…In a randomized trial, 1845 patients undergoing PCI were assigned to receive either everolimus-eluting bioresorbable vascular scaffolds or everolimus-eluting…”
Get full text

Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction by Ouweneel, Dagmar M., Eriksen, Erlend, Sjauw, Krischan D., van Dongen, Ivo M., Hirsch, Alexander, Packer, Erik J.S., Vis, M. Marije, Wykrzykowska, Joanna J., Koch, Karel T., Baan, Jan, de Winter, Robbert J., Piek, Jan J., Lagrand, Wim K., de Mol, Bas A.J.M., Tijssen, Jan G.P., Henriques, José P.S.

“…Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains high. Short-term mechanical…”
Get full text

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile by van Nood, Els, Vrieze, Anne, Nieuwdorp, Max, Fuentes, Susana, Zoetendal, Erwin G, de Vos, Willem M, Visser, Caroline E, Kuijper, Ed J, Bartelsman, Joep F.W.M, Tijssen, Jan G.P, Speelman, Peter, Dijkgraaf, Marcel G.W, Keller, Josbert J

“…Clostridium difficile infection can be life-threatening and difficult to treat, with frequent relapses. In this study in patients with recurrent C. difficile…”
Get full text

1021 Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction by Nijveldt, Robin, Hirsch, Alexander, Beek, Aernout M, Haeck, Joost DE, Koch, Karel T, Henriques, Jose PS, Schaaf, Rene van der J, Vis, Marije M, Baan, Jan, de Winter, Robbert J, Tijssen, Jan GP, van Rossum, Albert C, Piek, Jan J

Get full text

Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial by Henriques, José P S, Hoebers, Loes P, Råmunddal, Truls, Laanmets, Peep, Eriksen, Erlend, Bax, Matthijs, Ioanes, Dan, Suttorp, Maarten J, Strauss, Bradley H, Barbato, Emanuele, Nijveldt, Robin, van Rossum, Albert C, Marques, Koen M, Elias, Joëlle, van Dongen, Ivo M, Claessen, Bimmer E P M, Tijssen, Jan G, van der Schaaf, René J

“…In 10% to 15% of patients with ST-segment elevation myocardial infarction (STEMI), concurrent coronary chronic total occlusion (CTO) in a non-infarct-related…”
Get full text

Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement by Vlastra, Wieneke, Chandrasekhar, Jaya, García Del Blanco, Bruno, Tchétché, Didier, de Brito, Fabio S., Barbanti, Marco, Kornowski, Ran, Latib, Azeem, D’Onofrio, Augusto, Ribichini, Flavio, Baan, Jan, Tijssen, Jan G.P., Moreno, Raul, Dumonteil, Nicolas, Tarasoutchi, Flavio, Sartori, Samantha, D’Errigo, Paola, Tarantini, Giuseppe, Lunardi, Mattia, Orvin, Katia, Pagnesi, Matteo, Berenguer, Alberto, Modine, Thomas, Dangas, George, Mehran, Roxana, Piek, Jan J., Delewi, Ronak

“…Transfemoral aortic valve replacement (TAVR) is a guideline-recommended treatment option for patients with severe aortic valve stenosis. Women and men present…”
Get full text

Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation by Pluymaekers, Nikki A.H.A, Dudink, Elton A.M.P, Luermans, Justin G.L.M, Meeder, Joan G, Lenderink, Timo, Widdershoven, Jos, Bucx, Jeroen J.J, Rienstra, Michiel, Kamp, Otto, Van Opstal, Jurren M, Alings, Marco, Oomen, Anton, Kirchhof, Charles J, Van Dijk, Vincent F, Ramanna, Hemanth, Liem, Anho, Dekker, Lukas R, Essers, Brigitte A.B, Tijssen, Jan G.P, Van Gelder, Isabelle C, Crijns, Harry J.G.M

“…Patients presenting within 36 hours after the onset of atrial fibrillation were randomly assigned to undergo early cardioversion or to receive rate-control…”
Get full text

Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Meta-Analysis of Individual Patient Data by FOX, Keith A. A, CLAYTON, Tim C, DAMMAN, Peter, POCOCK, Stuart J, DE WINTER, Robbert J, TIJSSEN, Jan G. P, LAGERQVIST, Bo, WALLENTIN, Lars

“…This study was designed to determine: 1) whether a routine invasive (RI) strategy reduces the long-term frequency of cardiovascular death or nonfatal…”
Get full text

B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction by van Veldhuisen, Dirk J., MD, PhD, Linssen, Gerard C.M., MD, PhD, Jaarsma, Tiny, RN, PhD, van Gilst, Wiek H., PhD, Hoes, Arno W., MD, PhD, Tijssen, Jan G.P., PhD, Paulus, Walter J., MD, PhD, Voors, Adriaan A., MD, PhD, Hillege, Hans L., MD, PhD

“…Objectives This study sought to determine the prognostic value of B-type natriuretic peptide (BNP) in patients with heart failure with preserved ejection…”
Get full text

Lenient versus Strict Rate Control in Patients with Atrial Fibrillation by Van Gelder, Isabelle C, Groenveld, Hessel F, Crijns, Harry J.G.M, Tuininga, Ype S, Tijssen, Jan G.P, Alings, A. Marco, Hillege, Hans L, Bergsma-Kadijk, Johanna A, Cornel, Jan H, Kamp, Otto, Tukkie, Raymond, Bosker, Hans A, Van Veldhuisen, Dirk J, Van den Berg, Maarten P

“…This clinical trial of outcomes in patients with atrial fibrillation showed that lenient rate control (resting heart rate, <110 beats per minute) was not…”
Get full text